Inter-Eye Symmetry in Geographic Atrophy Across Structural, Spatial, and Lesion-Resolved Optical Coherence Tomography Metrics
This study demonstrates that while geographic atrophy exhibits strong inter-eye symmetry in total retinal pigment epithelium and outer retinal atrophy (RORA) area, fellow eyes show significantly greater variability in photoreceptor-related biomarkers, spatial features, and lesion counts, indicating that bilateral symmetry in this condition is biomarker- and scale-dependent.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Age-related macular degeneration is a leading cause of vision loss in older adults, slowly eroding the central part of the retina responsible for sharp sight. In its most advanced form, known as geographic atrophy, patches of light-sensitive cells and their supporting layers simply disappear, leaving behind permanent blind spots. Because this condition almost always affects both eyes, doctors and researchers have long operated on the assumption that the two eyes are mirror images of one another. If the disease has destroyed a certain amount of tissue in the left eye, it was generally believed that the right eye would show a very similar amount of damage. This idea of perfect symmetry has been useful, allowing scientists to use one eye as a control while testing treatments on the other, effectively turning a single patient into their own experiment.
However, this assumption relies on looking at the big picture. When researchers examine the eye with standard cameras, they see the total size of the damaged areas, and the two eyes do look quite similar. But the eye is a complex, layered structure, and modern imaging technology can now peer inside those layers to see the specific architecture of the damage. The question remained: if the total size of the damage is the same in both eyes, is the detailed structure of that damage also identical? A new study from Moorfields Eye Hospital in London set out to test this by looking at the microscopic details of geographic atrophy in both eyes of the same people, asking whether the symmetry holds up when we zoom in on the specific layers of the retina and the shape of the lesions.
The researchers gathered data from over one hundred patients who had already developed significant geographic atrophy in both eyes. They used a high-resolution imaging technique called spectral-domain optical coherence tomography, which acts like a microscopic cross-section of the eye, allowing them to see individual layers of tissue without cutting the eye open. From these scans, they generated detailed maps of four different types of damage: the loss of the outer retinal layers, the loss of a specific light-sensitive band called the ellipsoid zone, the loss of the interdigitation zone where cells connect, and a combination of these losses. They then compared the right eye to the left eye for every single patient, measuring not just the total area of damage, but also the size of the largest single patch, the distance of the damage from the center of vision, and the number of separate patches present.
The results revealed that the symmetry between the two eyes depends entirely on what is being measured. When the team looked at the total area of the outer retinal loss, the two eyes were remarkably similar. The measurements for the left and right eyes tracked closely together, with an average difference of just over two square millimeters. This confirmed that for the broad, overall burden of the disease, the eyes do behave as a matched pair. However, as soon as the researchers switched their focus to the more granular details, the symmetry began to unravel. When they measured the loss of the specific light-sensitive bands, the agreement between the eyes dropped significantly. The differences between the left and right eyes became much larger, with average discrepancies jumping to over seven square millimeters for some of these finer features.
The study also found that the eyes often differed in how the damage was organized. Two patients might have the same total amount of damaged tissue, but one eye could have a single large, merged patch while the other eye had many small, scattered spots. The number of separate lesions showed very little agreement between the two eyes, with an average difference of more than two distinct patches per person. This means that while the total volume of destruction might be comparable, the way that destruction is arranged—whether it is one big hole or a constellation of smaller ones—can be completely different in each eye. Furthermore, the location of the damage relative to the center of vision varied, and the distance from the central point of sight was not always the same in both eyes.
These findings suggest that while the broad strokes of geographic atrophy are shared between the two eyes, the fine details are not. The assumption that one eye can perfectly predict the other holds true for the total size of the atrophy, but it breaks down when looking at the specific layers of the retina or the arrangement of the lesions. This has important implications for how future clinical trials are designed. If researchers are testing a new drug by comparing a treated eye to a control eye, they can be confident that the overall size of the damage is a fair comparison. But if they are trying to measure changes in the specific light-sensitive layers or the number of separate lesions, they cannot assume the eyes are interchangeable. The study concludes that while the eyes are partners in the disease, they are not identical twins when it comes to the microscopic architecture of their damage.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.